The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and With Type 1 and 2 Diabetes: an Exploratory Study
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
Exhaled volatile organic compounds will be measured during daytime with the goal to identifying circadian variability. The study incudes three subgroups: people without diabetes, people with type 1 diabetes, and people with type 2 diabetes. A total of 60 people will be recruited for the study.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
⁃ Subgroup 1:
• Age 18 or older
• HbA1c below 6.5%
• Written informed consent
⁃ Subgroup 2:
• Age 18 or older
• T1D (Type 1 diabetes) with MDI (multiple daily injection) or CSII (Continuous subcutaneous insulin infusion therapy) therapy \>1 year
• Written informed consent
⁃ Subgroup 3
• Age 18 or older
• T2D (Type 2 diabetes) with oral antidiabetic medication or insulin therapy
• Written informed consent
Locations
Other Locations
Switzerland
University of Bern
RECRUITING
Bern
Contact Information
Primary
Lilian Witthauer
lilian.witthauer@unibe.ch
+41 31 664 22 77
Time Frame
Start Date: 2023-08-07
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 60
Treatments
People without diabetes
People with type 1 diabetes
People with type 2 diabetes
Related Therapeutic Areas
Sponsors
Leads: University of Bern
Collaborators: DCB Research AG, Insel Gruppe AG, University Hospital Bern